C57BL/6Ola-Nmnat1tm1Cole

Status

Available to order

EMMA IDEM:15683
Citation informationRRID:IMSR_EM:15683 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6Ola-Nmnat1tm1Cole
Alternative nameC57BL/6Ola-Nmnat1
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolNmnat1tm1Cole
Gene/Transgene symbolNmnat1

Information from provider

ProviderMichael Coleman
Provider affiliationThe Babraham Institute
Genetic informationNmnat1tm1Cole have floxed exons 2 and 3 in the gene Nmnat1. The mice were generated to test the hypothesis that deletion of Nmnat1 might induce spontaneous axon degeneration or accelerate injury-induced Wallerian degeneration. The reason for making this hypothesis is that slow Wallerian degeneration (WldS) mice uniquely express a fusion protein of the N-terminal 70 amino acids of ubiquitination factor Ube4b and full length Nmnat1 (Mack et al., Nat. Neurosci. 4: 1199-1206). If overexpressing Nmnat1 in this way contributes to delaying axon degeneration, then reducing its expression might accelerate axon degeneration, giving us important clues about the mechanism of action of WldS. NAD is also implicated in regulation of gene expression via NAD-dependent histone deacetylases (sirtuins) and in regulation of apoptosis via polyADP ribose polymerase (PARP), so these mice may be useful for such studies.
Phenotypic informationHomozygous:
No reported phenotype

Heterozygous:
No reported phenotype
Breeding historyThis line has been produced using C57BL/6JOlaHsd mice carrying a deletion in the alpha-synuclein allele. The mutation is congenic on this background.
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requirednot known
Immunocompromisednot known

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased mean corpuscular volume / IMPC
  • abnormal bone structure / IMPC
  • increased bone mineral content / IMPC
MGI phenotypes (gene matching)
  • abnormal retina morphology / MGI
  • retinal degeneration / MGI
  • abnormal retinal vasculature morphology / MGI
  • no phenotypic analysis / MGI
  • nervous system phenotype / MGI
  • abnormal retinal inner nuclear layer morphology / MGI
  • abnormal rod electrophysiology / MGI
  • abnormal cone electrophysiology / MGI
  • growth/size/body region phenotype / MGI
  • behavior/neurological phenotype / MGI
  • reproductive system phenotype / MGI
  • retinal pigment epithelium atrophy / MGI
  • impaired pupillary reflex / MGI
  • retinal photoreceptor degeneration / MGI
  • thin retinal inner nuclear layer / MGI
  • disorganized retinal inner nuclear layer / MGI
  • thin retinal outer nuclear layer / MGI
  • retinal outer nuclear layer degeneration / MGI
  • photoreceptor inner segment degeneration / MGI
  • photoreceptor outer segment degeneration / MGI
  • mortality/aging / MGI
  • prenatal lethality, complete penetrance / MGI
  • decreased total retina thickness / MGI
  • decreased a wave amplitude / MGI
  • decreased b wave amplitude / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).